The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia

NCT06883734 | Completed

• 1 other identifier: SelcukU-GUzun-002
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study was aimed to examine the effectiveness (illness management and recovery, engulfment, quality of life) of a 12-week the Illness Management Skills Training applied to patients with schizophrenia. The main questions it aims to answer are: Hypothesis (H1-1): Illness Management Skills Training applied intervention group has lower engulfment than the control group. Hypothesis (H1-2): Illness Management Skills Training applied intervention group has higher quality of life than the control group. Hypothesis (H1-3): Illness Management Skills Training applied intervention group has higher illness management and recovery level than the control group. Researchers were compared the Illness Management Skills Training to a control group (no intervention) to see if the Illness Management Skills Training works on engulfment, quality of life, illness management and recovery in patients with schizophrenia. Participants were: \- attended the Illness Management Skills Training, one session per week for 12 weeks, 60 minutes per session, in addition to routine outpatient clinic check-ups.

Conditions

Schizophenia Disorder

Keywords

Schizophrenia; engulfment; quality of life; illness management; recovery; Illness Management Skills Training; psychiatric nursing

Outcome Measures

Primary Outcomes (1)

• Illness management and recovery total mean score

  The Illness Management and Recovery Scale-Patient Form total score from the scale is 15-75. Increasing scores from the scale indicate that illness management and recovery also increase.

  From enrollment to the end of training at 12 weeks

Secondary Outcomes (2)

• Engulfment total mean score

  From enrollment to the end of training at 12 weeks

• Physical function, social function, physical role difficulty, emotional role difficulty, mental health, energy/vitality, pain and general health Physical and Mental Component Summary Scale mean scores

  From enrollment to the end of training at 12 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group was a group of 25 people consisting of patients with schizophrenia who followed the 12-week Illness Management Skills Training.

Behavioral: Illness Management Skills Training

Control

NO INTERVENTION

The control group consisted of 25 patients with schizophrenia who attended routine outpatient clinic check-ups for 12 weeks without any intervention.

Interventions

Illness Management Skills Training BEHAVIORAL

In this study, in addition to routine outpatient clinic check-ups, 12 sessions of Illness Management Skills Training were applied to the intervention group of 25 patients, each in four separate groups of 6+6+6+7 patients (Group 1, Group 2, Group 3, Group 4), once a week, for 60 minutes each. The training consisted of 1) Introduction-Getting Acquainted, 2) Recovery Goals, 3) Understanding Schizophrenia-1, 4) Understanding Schizophrenia-2, 5) Stress Vulnerability Model and Coping with Stress-1, 6) Stress Vulnerability Model and Coping with Stress-2, 7) Learning About Medication, 8) Using Medication Effectively and Monitoring Treatment, 9) Coping with Persistent Symptoms, 10) Recognizing and Monitoring Warning Signs, 11) Warning Signs My Emergency Plan, and 12) Termination sessions.

Intervention

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being between the ages of 18-65,
• Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
• Being registered with the Selcuk University Faculty of Medical Hospital Mental Health and Diseases Polyclinic,
• Coming to the polyclinic for regular check-ups,
• Getting a mild/moderate score from the Positive and Negative Syndrome Scale (PANSS),
• Taking medication regularly,
• Being at least literate.

You may not qualify if:

• Having an organic mental disorder or mental retardation,
• Having a visual or hearing impairment,
• Participating in a program similar to the intervention to be implemented.

Sponsors & Collaborators

• Neslihan Lok: lead
• Selcuk University: collaborator

Study Sites (1)

Selcuk University Faculty of Medical Hospital

Konya, 42230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Study Officials

• Neslihan Lok, Prof. Dr

  Selcuk University

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Prof. Dr, Study Director

Model Details: This study was a randomized controlled trial with pre-test and post-test control groups.

Study Record Dates

• First Submitted: March 13, 2025
• First Posted: March 19, 2025
• Study Start: August 15, 2024
• Primary Completion: January 31, 2025
• Study Completion: February 17, 2025
• Last Updated: March 21, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)